Epigenomics AG Stock Deutsche Boerse AG
Stocks
ECX
DE000A11QW50
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.785 EUR | -1.92% |
|
+9.51% | -4.03% |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-07-22 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 763K 870K 707K 650K 1.23M 83.26M 1.25M 8.42M 3.3M 40.89M 3.27M 3.2M 141M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.73M 13.37M 10.86M 10M 18.91M 1.28B 19.28M 129M 50.78M 629M 50.22M 49.12M 2.17B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.92% |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 2023-02-28 |
Alexander Link
BRD | Director/Board Member | 55 | 2020-05-31 |
Jochen Hummel
BRD | Director/Board Member | 56 | 2024-02-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.92% | +9.51% | - | - | 870K | |
| +0.90% | -0.89% | +112.26% | +101.54% | 4.59B | |
| -0.19% | -2.23% | +77.83% | +185.60% | 3.36B | |
| +1.08% | +1.16% | -26.22% | -38.59% | 2.07B | |
| -4.49% | -3.58% | +116.04% | -47.40% | 1.8B | |
| +0.88% | -1.03% | +42.87% | +184.47% | 1.49B | |
| +4.43% | +7.80% | +132.97% | -50.51% | 938M | |
| -1.90% | -2.07% | -11.78% | +36.45% | 868M | |
| +2.24% | +3.08% | -0.46% | - | 501M | |
| -2.32% | -6.03% | -38.25% | -19.63% | 471M | |
| Average | -0.13% | +0.05% | +45.03% | +43.99% | 1.79B | |
| Weighted average by Cap. | +0.09% | -0.26% | +67.85% | +75.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.36K 22.23K 20.45K 38.69K 2.62M 39.44K 265K 104K 1.29M 103K 101K 4.44M |
| Net income | -3.35M -3.82M -3.1M -2.86M -5.4M -366M -5.51M -37M -14.51M -180M -14.35M -14.04M -620M | -314K -358K -291K -268K -506K -34.26M -516K -3.47M -1.36M -16.83M -1.34M -1.31M -58.11M |
| Net Debt | 10.46M 11.92M 9.68M 8.91M 16.85M 1.14B 17.18M 115M 45.26M 560M 44.76M 43.78M 1.93B | 10.97M 12.5M 10.16M 9.35M 17.68M 1.2B 18.02M 121M 47.48M 588M 46.95M 45.93M 2.03B |
Employees
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ECX Stock
- ECX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
